The global signifor market is expected to grow at a significant CAGR during the forecast period (2021-2027). This medication contains Pasieotide in a long-acting version. When surgery has not been entirely effective or cannot be utilised to repair a problem, pasireotide is used to treat it. This condition is known as Cushing’s Syndrome. When the body produces too much of a hormone called cortisol, Cushing's disease develops. Excessive blood pressure, high blood sugar, and other issues can result from too much cortisol in the body. Pasireotide reduces the quantity of cortisol produced by the body.

According to the National Library of Medicine from NCBI, Endogenous Cushing's syndrome is an extremely rare condition, with about 2-4 cases per million people diagnosed each year. Ectopic ACTH secretion cases are often misdiagnosed. Cushing's disease is the most common cause of endogenous Cushing's syndrome that is 5 to 6 times as common as adrenal Cushing's syndrome, with an annual incidence of 1.2 to 2.4 cases per million people. Women are 3-8 times more likely than males to have Cushing's disease. Adrenal tumours are 3 times more common in women, while Cushing's disease caused by adrenal tumours is 3-5 times more common. The rising incidence of Cushing’s disease, therefore, results in a surge in demand for Signifor thereby driving the market growth.

In July 2019, Recordati announced that it has reached an agreement with Novartis to acquire global rights to Signifor and Signifor LAR for the treatment of Cushing's disease and acromegaly in adult patients for whom surgery is not an option or has failed. Signifor's global sales in 2018 were $ 72 million.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Type 

o By Application 

• Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Novartis and Recordati.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Signifor Market by Segments

By Type

• Injection
• Powder

By Application

• Hospital
• Homecare

Global Signifor Market by Region